Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

NCT06290856 · clinicaltrials.gov ↗

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped The platform used for detecting ctDNA was not sensitive enough.

Conditions

Metastatic Colorectal Cancer
Pancreas Adenocarcinoma
Cholangiocarcinoma

Interventions

DIAGNOSTIC_TEST: Multiplex PCR-test for circulating tumor DNA

Sponsor

Oslo University Hospital